Document Detail


Preventing delirium in the intensive care unit.
MedLine Citation:
PMID:  23182527     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Delirium in the intensive care unit (ICU) is exceedingly common, and risk factors for delirium among the critically ill are nearly ubiquitous. Addressing modifiable risk factors including sedation management, deliriogenic medications, immobility, and sleep disruption can help to prevent and reduce the duration of this deadly syndrome. The ABCDE approach to critical care is a bundled approach that clinicians can implement for many patients treated in their ICUs to prevent the adverse outcomes associated with delirium and critical illness.
Authors:
Nathan E Brummel; Timothy D Girard
Related Documents :
22973617 - Establishing an acute care nursing bed unit size: employing a decision matrix framework.
9369637 - The innocent heart murmur in children.
24603677 - Integrating palliative care into critical care: a quality improvement study.
17566527 - Perspectives of a parent and a provider for children with special health care needs.
19288947 - Assessment of asthma control using the asthma control test at a tertiary care centre in...
8874297 - Planning patient services for intermediate care units: insights based on care for inten...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Critical care clinics     Volume:  29     ISSN:  1557-8232     ISO Abbreviation:  Crit Care Clin     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-11-27     Completed Date:  2013-05-09     Revised Date:  2014-01-10    
Medline Journal Info:
Nlm Unique ID:  8507720     Medline TA:  Crit Care Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  51-65     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics, Opioid / administration & dosage,  adverse effects,  therapeutic use
Antipsychotic Agents / administration & dosage,  therapeutic use
Chemoprevention / methods
Comorbidity
Critical Illness*
Delirium / etiology,  prevention & control*,  therapy
Health Facility Environment
Humans
Hypnotics and Sedatives / adverse effects*,  therapeutic use
Immobilization / adverse effects
Intensive Care Units / standards
Length of Stay
Pain / complications
Pain Management*
Patient Isolation
Respiration, Artificial / adverse effects
Risk Factors
Sleep Deprivation / complications*
Grant Support
ID/Acronym/Agency:
K23AG034257/AG/NIA NIH HHS; KL2 RR024977/RR/NCRR NIH HHS; KL2 TR000446/TR/NCATS NIH HHS; T32 HL087738/HL/NHLBI NIH HHS; T32HL087738/HL/NHLBI NIH HHS; TL1 RR024978/RR/NCRR NIH HHS; TL1 TR000447/TR/NCATS NIH HHS; UL1 RR024975/RR/NCRR NIH HHS; UL1 TR000445/TR/NCATS NIH HHS
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Antipsychotic Agents; 0/Hypnotics and Sedatives
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ventilator-associated Complications, Including Infection-related Complications: The Way Forward.
Next Document:  Sedation and mobility: changing the paradigm.